60 Degrees Pharmaceuticals Inc (SXTP)

Currency in USD
0.4682
-0.0318(-6.36%)
Closed·
0.5077+0.0395(+8.44%)
·
Advertisement
Unusual Post-Market activity
SXTP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.46000.4998
52 wk Range
0.45008.6200
Key Statistics
Prev. Close
0.5
Open
0.4998
Day's Range
0.46-0.4998
52 wk Range
0.45-8.62
Volume
51.29K
Average Volume (3m)
401.78K
1-Year Change
-53.6436%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SXTP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold---Downgrade20/05/2026

Earnings

Latest Release
14/08/2026
EPS / Forecast
-0.90 / -1.35
Revenue / Forecast
207.9K / --
EPS Revisions
Last 90 days

Compare SXTP to Peers and Sector

Metrics to compare
SXTP
Peers
Sector
Relationship
P/E Ratio
0.0x−3.8x−0.2x
PEG Ratio
0.00−0.060.00
Price/Book
0.0x1.7x2.6x
Price / LTM Sales
0.0x1.9x2.6x
Upside (Analyst Target)
-125.7%76.9%
Fair Value Upside
Unlock17.9%14.9%Unlock

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.

People Also Watch

1.3800
NXL
-0.72%
0.6426
AMOD
-12.21%
0.900
DKI
-10.89%
1.570
FLYE
-2.48%
2.400
WCT
-4.38%

FAQ

What Is the 60 Degrees Pharmaceuticals (NASDAQ: SXTP) Share Price Today?

The 60 Degrees Pharmaceuticals stock price today is 0.4682 USD.

What Stock Exchange Does 60 Degrees Pharmaceuticals (SXTP) Trade On?

60 Degrees Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for 60 Degrees Pharmaceuticals?

The stock symbol (also called a 'ticker') for 60 Degrees Pharmaceuticals is "SXTP."

What Is the Current 60 Degrees Pharmaceuticals Market Capitalisation?

As of today, 60 Degrees Pharmaceuticals (NASDAQ: SXTP) market cap is 29.5200M USD.

What Is 60 Degrees Pharmaceuticals's (SXTP) Earnings Per Share (TTM)?

The 60 Degrees Pharmaceuticals EPS is currently -3.93 (Trailing Twelve Months).

When Is the Next 60 Degrees Pharmaceuticals Earnings Date?

60 Degrees Pharmaceuticals's next earnings report will be released on 23/11/2026.

Is SXTP a Buy or Sell From a Technical Analyst Perspective?

Based on today's 60 Degrees Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for SXTP stock is Strong Sell.

How Many Times Has 60 Degrees Pharmaceuticals Stock Split?

60 Degrees Pharmaceuticals has split 0 times. (See the SXTP stock split history page for full effective split date and price information.)

What is the current trading status of 60 Degrees Pharmaceuticals (NASDAQ: SXTP)?

As of 21/11/2026, 60 Degrees Pharmaceuticals (SXTP) is trading at a share price of 0.4682 USD, with a previous close of 0.5000 USD. The stock has fluctuated within a day range of 0.4600 USD to 0.4998 USD, while its 52-week range spans from 0.4500 USD to 8.6200 USD.

What Is the SXTP Premarket Price?

SXTP's last pre-market stock price is 0.4650 USD. The pre-market share volume is 1,450.0000, and the stock has decreased by -0.0350, or -7.0000%.

What Is the SXTP After Hours Price?

SXTP's last after hours stock price is 0.5077 USD, the stock has decreased by 0.0395, or 8.4400%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.